| Original language | English |
|---|---|
| Pages (from-to) | 1640-1641 |
| Number of pages | 2 |
| Journal | Pharmacoepidemiology and Drug Safety |
| Volume | 28 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - Dec 2019 |
The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) - EMA Joint Big Data Task Force
Anton Pottegård, Olaf Klungel, Almut Winterstein, Krista Huybrechts, Jesper Hallas, Sebastian Schneeweiss, Stephen Evans, Andrew Bate, Lisa Pont, Gianluca Trifirò, Meredith Smith, Alison Bourke
- Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.
- Pharmaceutical Outcomes and Policy and Center for Drug Evaluation and Safety, University of Florida, Gainesville, Florida.
- Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
- Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
- Epidemiology, New York University, New York City, New York.
- Pharmacy Department, Faculty of Health, University of Technology Sydney, Sydney, New South Wales, Australia.
- Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
- School of Pharmacy, University of Southern California, Los Angeles, California.
- Real World Solutions, IQVIA, London, UK.
Research output: Contribution to journal › Article › Academic › peer-review